Weight-loss treatments: liraglutide with or without orlistat
Part of Hormones & metabolism clinical trials.
This study compares two weight-loss medicines: liraglutide (a daily injection) and orlistat (a pill), given alone or together, over 24 weeks. It aims to see which approach is safer and works better for people who are overweight or have obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your body mass index (BMI) is 30–35, or 27 or above with at least one weight-related health issue like high blood pressure, type 2 diabetes, or high cholesterol
- You are able to take part in treatment and follow-up for 24 weeks
- You do not have serious liver, kidney, or thyroid disease, certain stomach or intestinal conditions, or a history of medullary thyroid cancer
- You are not pregnant, breastfeeding, or planning pregnancy during the study
- You do not have type 1 diabetes, cancer, or severe heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests whether adding an investigational drug (LUM-201) to a standard weight-loss medication (semaglutide) helps older adults with obesity lose more weight safely. It aims to see if the combination works better than semaglutide alone.
This trial tests whether taking a weight-loss medication (liraglutide) together with standard dietary advice before weight-loss surgery helps more than dietary advice alone. If you're planning such surgery, this could help you lose more weight beforehand, which might make surgery safer and more effective.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Overweight and Obese Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.